|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 87.99 USD | -0.44% |
|
-18.21% | -11.78% |
| 07-15 | Celcuity Inc. - Special Call | |
| 07-15 | Celcuity shares fall as launch delay eclipses US approval for breast cancer drug | RE |
Company Valuation: Celcuity Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 196.8 | 303.6 | 367.7 | 486 | 4,615 | 4,310 | - | - |
| Change | - | 54.26% | 21.13% | 32.18% | 849.56% | -6.61% | - | - |
| Enterprise Value (EV) | 196.8 | 303.6 | 367.7 | 486 | 4,615 | 4,310 | 4,310 | 4,310 |
| Change | - | 54.26% | 21.13% | 32.18% | 849.56% | -6.61% | 0% | 0% |
| P/E | -5.97x | -5.31x | -5.42x | -4.63x | -26.3x | -21x | -176x | 30x |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | -0.3x | -2.86x | -0.89x | -0.8x | -1.9x | 2x | -0x |
| Capitalization / Revenue | - | - | - | - | - | 111x | 11x | 6.49x |
| EV / Revenue | - | - | - | - | - | 111x | 11x | 6.49x |
| EV / EBITDA | - | - | -0x | -0x | -0x | -16.9x | -70.5x | - |
| EV / EBIT | -0x | -0x | -0x | -0x | -0x | -20.2x | -347x | 21.5x |
| EV / FCF | - | - | -0x | -0x | -0x | -21.4x | -96.2x | 15.3x |
| FCF Yield | - | - | -14.7% | -17.2% | -3.33% | -4.67% | -1.04% | 6.52% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -2.21 | -2.64 | -2.69 | -2.83 | -3.79 | -4.216 | -0.5018 | 2.95 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | - | - | - | - | - | 38.87 | 393.4 | 663.6 |
| EBITDA 1 | - | - | -66.09 | -113.1 | -172 | -255.2 | -61.1 | - |
| EBIT 1 | -28.36 | -39.39 | -66.23 | -113.3 | -172.2 | -213.1 | -12.42 | 200.1 |
| Net income 1 | -29.61 | -40.37 | -63.78 | -111.8 | -177 | -221.1 | -34.24 | 177.9 |
| Net Debt | - | - | - | - | - | - | - | - |
| Reference price 2 | 13.19 | 14.01 | 14.57 | 13.09 | 99.74 | 88.38 | 88.38 | 88.38 |
| Nbr of stocks (in thousands) | 14,919 | 21,667 | 25,238 | 37,130 | 46,271 | 48,766 | - | - |
| Announcement Date | 3/23/22 | 3/23/23 | 3/27/24 | 3/31/25 | 3/25/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -20.96x | - | - | - | 4.31B | |
| 32.53x | 8.12x | 25.44x | 0.05% | 53.83B | |
| 19.5x | 6.01x | 13.15x | 1.63% | 52.1B | |
| -42.48x | 13.5x | -39.59x | -.--% | 23.48B | |
| -18.22x | 4.32x | -7.57x | -.--% | 23.13B | |
| 24.24x | 4.75x | 12.54x | -.--% | 19.36B | |
| 24.39x | 4.78x | 15.56x | -.--% | 17.56B | |
| 45.88x | 18.59x | 47.88x | 0.08% | 15.2B | |
| -505.73x | 35.47x | -1462.84x | -.--% | 14.83B | |
| 17.57x | 5.11x | 11.88x | -.--% | 14.06B | |
| Average | -42.33x | 11.18x | -153.73x | 0.2% | 23.79B | |
| Weighted average by Cap. | -18.49x | 9.52x | -82.77x | 0.38% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- CELC Stock
- Valuation Celcuity Inc.
Select your edition
All financial news and data tailored to specific country editions
